Results 151 to 160 of about 330,204 (355)

Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis

, 2023
Agustín Ciapponi, Mabel Berrueta, Jamile Ballivian, Ariel Bardach, Agustina Mazzoni, Steven A. Anderson, Fernando Argento, Karin Bok, Daniel Comandé, Erin Goucher, Beate Kampmann, Edward P K Parker, Federico Rodríguez Cairoli, Victoria Santa María, Andy Stergachis, Gérald Voss, Xu Xiong, Sabra Zaraa, Flor M. Muñoz, Ruth A. Karron, Sami L. Gottlieb, Pierre Buekens   +21 more
openalex   +1 more source

Dual‐Functional Ingestible Passive Capsules for High‐Throughput Intestinal Sampling with Sealed Containment and Targeted Drug Delivery

Advanced Robotics Research, EarlyView.
To address challenges in high‐throughput intestinal sampling with sealed containment and target drug delivery, we developed a dual‐functional ingestible passive capsule with a dual‐triggered control system based on pH‐response and mechanical actuation.
Libing Huang, Houyu Ling, Xizong Chen, Yufei Duan, Yu Liu, Shuntian Cai, Yandan Ren, Wenlong Li, Lei Ren, Miao Wang   +9 more
wiley   +1 more source

Inhaled Angiopoietin‐Like 4 Antisense Oligonucleotide Therapy for Lung Injury and Fibrosis

Advanced Science, EarlyView.
Inhaled antisense oligonucleotides targeting ANGPTL4 attenuate inflammation, preserve barrier integrity, and reduce fibrosis in both infectious and sterile lung injury models. Integrated transcriptomic analysis reveals a conserved ANGPTL4‐regulated gene network coordinating hypoxic, inflammatory, apoptotic, and stress‐response pathways.
Haiyang Fan, Yuanyang Tan, Junhang Zhang, Xiaoya Liu, Jing Qu, Damien Chua, Hong Sheng Cheng, Joseph Han Sol Kim, Yu Xuan Liu, Changfei Qin, Yingzi Liu, Dezhi Li, Jikang Qiu, Mengshi Chi, Mingmin Bi, Qiwei Zhang, Yun Li, Masoumeh Motamedi Joibari, Stefan K Nilsson, Nguan Soon Tan, Yunping Fan, Liang Li   +21 more
wiley   +1 more source

PIN16 COMPARATIVE CRITICAL REVIEW OF COST-EFFECTIVENESS TOOLS OF PNEUMOCOCCAL CONJUGATE VACCINE (PCV)

, 2010
Nathorn Chaiyakunapruk, Ratchadaporn Somkrua, Raymond Hutubessy, AMH Restrepo, Alessia Melegaro, John Edmunds, Philippe Beutels   +6 more
openalex   +1 more source

Tracking R_t of COVID-19 Vaccine Effectiveness Using Kalman Filter and SIRD Model

, 2021
Mahmoud Kaddour, Jinan Charafeddine, Nazih Moubayed   +2 more
openalex   +2 more sources

COVID-19 vaccine booster dose effectiveness among health workers: systematic review & meta-analysis [PDF]

, 2023
L. Bartolucci, Gianfranco Damiani, Domenico Pascucci, Denise Pires Marafon, Patrizia Laurenti   +4 more
openalex   +1 more source

Pre‐Encoded IFN‐I Sensitivity Exacerbates Memory T Cell Senescence in Solid Tumors

Advanced Science, EarlyView.
Type I interferon (IFN‐I) signaling promotes p21‐dependent cell cycle arrest in senescent tumor‐specific memory T cells, resulting in poor proliferative responses and solid tumor regression during cancer vaccination. Conversely, IFNα/β receptor blockade reinvigorates T cell proliferation to regress solid tumors and is more effective with increasing ...
Andrew Nguyen, Scott R Walsh, Li Deng, Lan Chen, Yonghong Wan   +4 more
wiley   +1 more source

Efficacy, effectiveness and safety of the adjuvanted influenza vaccine in the population aged 65 or over [PDF]

, 2023
M.P. Arrazola Martínez, José Marı́a Eiros Bouza, Pere Plans Rubió, Joan Puig‐Barberà, Jesús Ruiz-Aragón, Álvaro Torres Lana   +5 more
openalex   +1 more source

Human Papillomavirus (HPV) Vaccine: Attitudes, Behaviors, and Beliefs of At-Risk Women [PDF]

, 2008
Cervical cancer is primarily caused by human papillomavirus (HPV) and is the second most common cause of cancer-related mortality among women. Female college students may be at risk for contracting HPV based on their sexual behavior.
Caron, Rosemary M, Kispert, Elisabeth, McGrath, Robert J.   +2 more
core   +1 more source

Predicting vaccine effectiveness for mpox

Nature Communications
Abstract The Modified Vaccinia Ankara vaccine developed by Bavarian Nordic (MVA-BN) was widely deployed to prevent mpox during the 2022 global outbreak. This vaccine was initially approved for mpox based on its reported immunogenicity (from phase I/II trials) and effectiveness in animal models, rather than evidence of clinical ...
Berry, MT, Khan, SR, Schlub, TE, Notaras, A, Kunasekaran, M, Grulich, AE, MacIntyre, CR, Davenport, MP, Khoury, DS   +8 more
openaire   +4 more sources